Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.

Hirai K, Nomura T, Yamasaki M, Inoue T, Narimatsu T, Chisato Nakada PD, Yoshiyuki Tsukamoto PD, Matsuura K, Sato F, Moriyama M, Mimata H.

Urol Oncol. 2014 Feb;32(2):101-9. doi: 10.1016/j.urolonc.2012.09.005. Epub 2013 Feb 9.

PMID:
23403204
2.

Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.

Nomura T, Yamasaki M, Hirai K, Inoue T, Sato R, Matsuura K, Moriyama M, Sato F, Mimata H.

Mol Cancer. 2013 Apr 8;12:27. doi: 10.1186/1476-4598-12-27.

3.

Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells.

Yamasaki M, Nomura T, Sato F, Mimata H.

Urol Oncol. 2013 Oct;31(7):1124-31. doi: 10.1016/j.urolonc.2011.12.007. Epub 2012 Jan 5.

PMID:
22226664
4.

Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.

Dong Z, Liu Y, Lu S, Wang A, Lee K, Wang LH, Revelo M, Lu S.

Mol Endocrinol. 2006 Oct;20(10):2315-25. Epub 2006 Jun 8.

PMID:
16762975
5.

Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.

Kim SM, Park JH, Kim KD, Nam D, Shim BS, Kim SH, Ahn KS, Choi SH, Ahn KS.

Phytother Res. 2014 Mar;28(3):423-31. doi: 10.1002/ptr.5010. Epub 2013 May 20.

PMID:
23686889
6.

Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.

Lin KT, Gong J, Li CF, Jang TH, Chen WL, Chen HJ, Wang LH.

Cancer Res. 2012 Jun 15;72(12):3000-9. doi: 10.1158/0008-5472.CAN-11-2502. Epub 2012 Jun 1.

7.

Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.

Ummanni R, Teller S, Junker H, Zimmermann U, Venz S, Scharf C, Giebel J, Walther R.

FEBS J. 2008 Nov;275(22):5703-13. doi: 10.1111/j.1742-4658.2008.06697.x.

8.

Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.

Dong Z, Liu Y, Levin L, Oleksowicz L, Wang J, Lu S.

Oncol Rep. 2011 Jun;25(6):1511-6. doi: 10.3892/or.2011.1237. Epub 2011 Mar 29.

PMID:
21455584
9.

Clinical significance of increased guanine nucleotide exchange factor Vav3 expression in human gastric cancer.

Lin KY, Wang LH, Hseu YC, Fang CL, Yang HL, Kumar KJ, Tai C, Uen YH.

Mol Cancer Res. 2012 Jun;10(6):750-9. doi: 10.1158/1541-7786.MCR-11-0598-T. Epub 2012 Apr 27.

10.

Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.

Yamasaki M, Nomura T, Sato F, Mimata H.

Oncol Rep. 2007 Nov;18(5):1145-53.

PMID:
17914565
11.
13.

Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.

Liu Y, Mo JQ, Hu Q, Boivin G, Levin L, Lu S, Yang D, Dong Z, Lu S.

Cancer Res. 2008 Aug 1;68(15):6396-406. doi: 10.1158/0008-5472.CAN-08-0645.

14.

Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.

Harashima N, Inao T, Imamura R, Okano S, Suda T, Harada M.

Cancer Immunol Immunother. 2012 May;61(5):667-76. doi: 10.1007/s00262-011-1132-1. Epub 2011 Oct 29.

PMID:
22038398
15.

Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.

Tan B, Li Y, Zhao Q, Fan L, Wang D, Liu Y.

Tumour Biol. 2014 Feb;35(2):1481-8. doi: 10.1007/s13277-013-1204-2. Epub 2013 Sep 27.

PMID:
24072493
16.

Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.

Peacock SO, Fahrenholtz CD, Burnstein KL.

Mol Endocrinol. 2012 Dec;26(12):1967-79. doi: 10.1210/me.2012-1165. Epub 2012 Sep 28.

17.

The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.

Cui Z, Ren S, Lu J, Wang F, Xu W, Sun Y, Wei M, Chen J, Gao X, Xu C, Mao JH, Sun Y.

Urol Oncol. 2013 Oct;31(7):1117-23. doi: 10.1016/j.urolonc.2011.11.030. Epub 2012 Jan 20.

PMID:
22264502
18.

Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.

Rocchi P, Jugpal P, So A, Sinneman S, Ettinger S, Fazli L, Nelson C, Gleave M.

BJU Int. 2006 Nov;98(5):1082-9. Epub 2006 Jul 28.

19.

Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.

Sato R, Yamasaki M, Hirai K, Matsubara T, Nomura T, Sato F, Mimata H.

Oncol Rep. 2015 Jan;33(1):58-66. doi: 10.3892/or.2014.3586. Epub 2014 Nov 3.

20.

Small interfering RNA targeting HMGN5 induces apoptosis via modulation of a mitochondrial pathway and Bcl-2 family proteins in prostate cancer cells.

Zhang XY, Guo ZQ, Ji SQ, Zhang M, Jiang N, Li XS, Zhou LQ.

Asian J Androl. 2012 May;14(3):487-92. doi: 10.1038/aja.2012.18. Epub 2012 Apr 16.

Supplemental Content

Support Center